Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chipro is a German biotechnology company specializing in the production and development of high-quality chitin and chitosan derivatives for pharmaceutical, medical, and cosmetic applications. The company focuses on providing ultra-pure, medical-grade chitosan that serves as a versatile biomaterial for drug delivery systems, wound dressings, and regenerative medicine. Chipro's expertise lies in the precise characterization and modification of chitosan to meet stringent regulatory requirements for clinical use. By offering customized chitosan solutions, the company supports the development of advanced therapeutic products, including nanoparticle-based delivery vehicles and scaffolds for tissue engineering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chipro.